Alnylam Patient Education Liaisons (PELs) are professionals with backgrounds in nursing who can provide answers and information to you and your family about hereditary ATTR (hATTR) amyloidosis and treatment with ONPATTRO^® (patisiran), a prescription medicine that treats the polyneuropathy caused by hATTR amyloidosis in adults. PELs can provide disease and product education, connect you to additional resources, and answer questions about ONPATTRO.

The purpose of the Alnylam PEL team is to provide education to patients, their families, and caregivers.

PELs engage with patients one-on-one to provide education and participate in family meetings
PELs help raise awareness about hATTR amyloidosis in community health organizations and advocacy groups
PELs are employees of Alnylam Pharmaceuticals. They are not healthcare providers and should not be considered part of your healthcare team
PELs do not provide medical care or advice
All diagnosis and treatment decisions should be made by you and your doctor

Joanna, Alnylam Patient Education Liaison (PEL)

My own experiences really play a large part in how I deliver education to patients and their families.

JOANNA, Alnylam PEL

Request that an Alnylam PEL reach out to you to help answer questions you may have about hATTR amyloidosis and ONPATTRO. Registration is quick and easy—simply fill out the form below.

All fields required unless otherwise noted.

First Name

Last Name

Street address

City

State

Zip Code

Email address

Phone

OK to leave voicemail. (Optional)

I would like an Alnylam Patient Education Liaison to contact me with information about hATTR amyloidosis.

I understand that the Alnylam PEL is not providing me medical advice and is not part of my healthcare team.

By submitting this form, I agree to the Alnylam . I am 18 years or older, a US resident, and consent to the processing of my personal data per the terms outlined in the .

I understand that Alnylam will use reasonable technical and organizational measures to protect the information I share with the PEL and will not use or disclose it outside of the company.

I would like to receive updates from Alnylam Pharmaceuticals regarding marketing communications, customer surveys, or for market research surveys. (Optional)

Important Safety Information and Indication

Important Safety Information

What are the most important things I should know about ONPATTRO^® (patisiran)?

ONPATTRO can cause:

Infusion-related reactions
ONPATTRO is given as a drip into a vein (called an "intravenous infusion"). Reactions to this infusion may happen during treatment with ONPATTRO. Before each infusion you will be given medicines that help to lower the chance of infusion-related reactions.

Tell your doctor or nurse right away if you experience any of the following signs of an infusion-related reaction during treatment:
- Reddening of the face or body (flushing), skin warm
- Body aches or pain, including pain in the back, neck, or joints
- Feeling sick (nausea)
- Stomach pain
- Feeling short of breath, cough, or other breathing problems
- Headache
- Chest discomfort or chest pain
- Rash
- Chills
- Dizziness
- Feeling tired (fatigue)
- Rapid heart rate
- Facial swelling
If you have an infusion-related reaction, your doctor or nurse may slow down or stop your infusion, and you may need to take other medicines. When these reactions stop, or get better, your doctor or nurse may decide to start the infusion again.
Low Vitamin A levels
Treatment with ONPATTRO lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.

Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking ONPATTRO, talk to your doctor. Your doctor may refer you to an eye specialist.

What are the common side effects of ONPATTRO?

The most common side effects of ONPATTRO are respiratory infections, such as colds, sinus infections, and nasal congestion, and infusion-related reactions. These are not all the possible side effects of ONPATTRO. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Indication

What is ONPATTRO?

ONPATTRO is a prescription medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). ONPATTRO is used in adults only.

For additional information about ONPATTRO, please see the full Prescribing Information.

Important Safety Information and Indication

Important Safety Information

What are the most important things I should know about ONPATTRO^® (patisiran)?

ONPATTRO can cause:

Infusion-related reactions
ONPATTRO is given as a drip into a vein (called an "intravenous infusion"). Reactions to this infusion may happen during treatment with ONPATTRO. Before each infusion you will be given medicines that help to lower the chance of infusion-related reactions.

Tell your doctor or nurse right away if you experience any of the following signs of an infusion-related reaction during treatment:
- Reddening of the face or body (flushing), skin warm
- Body aches or pain, including pain in the back, neck, or joints
- Feeling sick (nausea)
- Stomach pain
- Feeling short of breath, cough, or other breathing problems
- Headache
- Chest discomfort or chest pain
- Rash
- Chills
- Dizziness
- Feeling tired (fatigue)
- Rapid heart rate
- Facial swelling
If you have an infusion-related reaction, your doctor or nurse may slow down or stop your infusion, and you may need to take other medicines. When these reactions stop, or get better, your doctor or nurse may decide to start the infusion again.
Low Vitamin A levels
Treatment with ONPATTRO lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.

Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking ONPATTRO, talk to your doctor. Your doctor may refer you to an eye specialist.

What are the common side effects of ONPATTRO?

Indication

What is ONPATTRO?

ONPATTRO is a prescription medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). ONPATTRO is used in adults only.

For additional information about ONPATTRO, please see the full Prescribing Information.

Connect with an Alnylam educator

Request that an Alnylam PEL reach out to you to help answer questions you may have about hATTR amyloidosis and ONPATTRO. Registration is quick and easy—simply fill out the form below.

Important Safety Information and Indication

Important Safety Information

What are the most important things I should know about ONPATTRO® (patisiran)?

What are the common side effects of ONPATTRO?

Indication

What is ONPATTRO?

Important Safety Information and Indication

Important Safety Information

What are the most important things I should know about ONPATTRO® (patisiran)?

What are the common side effects of ONPATTRO?

Indication

What is ONPATTRO?

What are the most important things I should know about ONPATTRO^® (patisiran)?

What are the most important things I should know about ONPATTRO^® (patisiran)?